What is guaiol?
Guaiol, also called champacol, is a plant compound classified as a sesquiterpenoid alcohol. Its formula is C₁₅H₂₆O. A fragrance supplier describes its scent as woody with a mild rose-like character and identifies guaiac wood oil as a source.
Guaiol appears in cannabis chemistry research, but finding it in a product does not establish a particular feeling or health benefit. The studies below range from chemical specifications to surveys, mixed plant oils and cancer experiments in cells and mice. Those sources answer very different questions.
Is 92°C really guaiol’s boiling point?
The frequently repeated 92°C figure needs care. Taiwan Tekho’s specification describes crystalline guaiol at 20°C and gives a melting range of 91–93°C. Cayman Chemical’s safety data sheet also lists a solid, while leaving the boiling range undetermined.
Melting means a solid becomes a liquid; boiling means a liquid becomes a gas. These are different properties. The supplier records reviewed here do not establish 92°C as guaiol’s boiling point, and we have not substituted another unverified number.
A compound being present in an essential oil does not mean its purified form must itself be liquid at room temperature. Physical-property tables should identify the material and measurement conditions before a number is reused.
How does guaiol make you feel?
The evidence reviewed does not establish a reliable relaxing, energizing or anxiety-producing effect from guaiol alone. A 2018 study surveyed patients of one cannabis supplier, then compared the chemistry of products rated most and least effective for anxiety relief.
Guaiol was associated with lower reported relief in that analysis. This was not a randomized experiment administering isolated guaiol. The products contained many compounds, and people selected and rated products rather than receiving blinded assignments. The finding cannot show that guaiol itself caused anxiety.
The authors disclosed employment, shareholding and consulting relationships with cannabis businesses. These relationships and the observational design matter when interpreting the result; neither invalidates it automatically. A product association is a research lead, not a dependable prediction for an individual.
Does the anti-inflammatory research test guaiol itself?
A commonly cited 2010 paper tested two leaf essential oils containing dozens of constituents. Guaiol was a major component of one oil, from Calycorectes sellowianus, but it was not tested separately in that experiment.
Both oils changed an immune-cell migration measure in the laboratory. Only the other oil, from Myrciaria tenella, significantly reduced swelling in the animal test reported in the abstract. This distinction gets lost when the paper is summarized simply as evidence of guaiol’s anti-inflammatory effects.
Our appraisal of this paper is limited to its original abstract. It does not demonstrate that isolated guaiol relieves inflammation or pain in people.
What do the cancer studies actually show?
A 2016 paper investigated guaiol in non-small cell lung cancer models and implicated RAD51, a protein involved in DNA repair. Its original abstract describes laboratory and animal findings. The protein is RAD51, not RAD5; neither name should be turned into a patient benefit claim.
A later study, published online in 2022 and in a 2023 journal issue, examined cancer cells and mice with implanted tumors. Researchers reported smaller tumors and changes in immune-cell activity after guaiol treatment. The principal mouse comparison used five animals per group.
That study investigated immunogenic cell death: whether dying cancer cells release signals that help engage an immune response. It was not a trial in people with lung cancer and did not test cannabis as a cancer treatment. The authors reported Chinese public research funding and no competing interests.
These experiments justify further investigation. They do not establish that guaiol prevents cancer, treats cancer in people or makes a cannabis product an effective cancer therapy.
Guaiol evidence at a glance
Check the material and the outcome before deciding what a study means.
| Question | Evidence reviewed | What remains unestablished |
|---|---|---|
| Physical properties | Supplier specifications for crystalline guaiol | A verified boiling point from these records |
| Anxiety and feelings | Survey linked to whole-product chemistry | A causal effect of isolated guaiol |
| Inflammation | Mixed essential oils in laboratory and animal tests | Human benefit from guaiol alone |
| Cancer | Cell experiments and small mouse studies | Cancer treatment effectiveness in people |
Safety and guaiol on a lab report
The reviewed evidence does not establish the long-term safety of concentrated guaiol in people. A research-chemical safety sheet is useful for identifying a material, but it is not a clinical safety study or a certificate for a finished cannabis product.
On a certificate of analysis, check the batch, units and reporting limits. A guaiol result describes the tested sample; it does not supply a proven rating for relaxation, anxiety relief or medical effectiveness. If a result is not detected, interpret it using that laboratory’s reporting definition rather than assuming absolute absence.
Our terpene-profile guide explains the numbers, while the related compound profiles show why each effects claim needs its own evidence.


